insights_auto
Why is QDEL up 4.53%?
Dive Deeperchevron_right
QDEL:NASDAQ
Quidelortho Corp
$10.85
arrow_upward
+4.53%(+0.47) 1D
Oct 2, 2:53:52 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for QDEL...
Open
$10.67
High
$11.18
Low
$10.46
Mkt. cap
744.04M
Avg. vol.
1.42M
Volume
1.15M
52-wk high
$35.58
52-wk low
$9.92
EPS
-$15.40
Beta
0.79
Shares outstanding
68.58M
No. of employees
6K
Open
$10.67
High
$11.18
Low
$10.46
Mkt. cap
744.04M
Avg. vol.
1.42M
Volume
1.15M
52-wk high
$35.58
52-wk low
$9.92
EPS
-$15.40
Beta
0.79
Shares outstanding
68.58M
No. of employees
6K
News stories
From web sources and news partners
bloomingbit
·
15 minutes ago
U.S. Stocks Turn Higher; Nasdaq Rises 1.10%
ChartMill
·
49 minutes ago
These S&P500 stocks are the most active in today's session
marketscreener.com
·
16 minutes ago
Nasdaq climbs to record after softer jobs data cools rate-hike expectations
StoneX
·
1 hour ago
Dow Jones Slide Shows What Rate Hike Bets Mean for Stocks
Profile
QuidelOrtho Corporation is an American manufacturer of diagnostic healthcare products that are sold worldwide.
On May 8, 2020 the U.S. Food and Drug Administration issued to Quidel the first emergency use authorization for a COVID-19 rapid antigen test, a new category of tests for use in the ongoing pandemic. These diagnostic tests quickly detect fragments of proteins found on or within the virus by testing samples collected from the nasal cavity using swabs. Wikipedia
About Quidelortho Corp
CEODouglas C Bryant
Employees6.5K
Founded1979
HeadquartersSan Diego, California, United States
SectorMedical device
Websitequidelortho.com